SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-18-003426
Filing Date
2018-05-08
Accepted
2018-05-08 16:06:13
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 m5118010q.htm 10-Q 599663
2 EXHIBIT 4.6 ex4_6.htm EX-4.6 156606
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 42153
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 105286
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 8067
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 7735
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 5282
8 EXHIBIT 32.2 ex32_2.htm EX-32.2 5707
  Complete submission text file 0001214659-18-003426.txt   3332382

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT hgen-20180331.xml EX-101.INS 557387
10 XBRL TAXONOMY EXTENSION SCHEMA hgen-20180331.xsd EX-101.SCH 36432
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hgen-20180331_cal.xml EX-101.CAL 40824
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hgen-20180331_def.xml EX-101.DEF 120946
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE hgen-20180331_lab.xml EX-101.LAB 270629
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hgen-20180331_pre.xml EX-101.PRE 193688
Mailing Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 18814543
SIC: 2834 Pharmaceutical Preparations